ArticleFuture virology2021

Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study.

Ajita Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.